<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR42">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gokbuget</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Dombret</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Bonifacio</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Reichle</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Graux</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Faul</surname>
    <given-names>C</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia</article-title>
  <source>Blood.</source>
  <year>2018</year>
  <volume>131</volume>
  <fpage>1522</fpage>
  <lpage>1531</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2017-08-798322</pub-id>
  <?supplied-pmid 29358182?>
  <pub-id pub-id-type="pmid">29358182</pub-id>
 </element-citation>
</ref>
